Kathryn Bollinger is an Ophthalmology physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingNIH funding
2 NIH research awards on record, funded 2011–2026 per NIH RePORTER. The latest:
- The Mechanism of Sigma 1 Receptor Mediated Neuroprotection in Glaucoma
Augusta University
FY2026$421,655R01EY027406 - The Mechanism of Sigma 1 Receptor Mediated Neuroprotection in Glaucoma
Augusta University
FY2025$421,655R01EY027406 - The Mechanism of Sigma 1 Receptor Mediated Neuroprotection in Glaucoma
Augusta University
FY2024$421,655R01EY027406
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Richard Spaide, MD
Vitreous Retina Macula Consultants of New York
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”